CN108126172A - A kind of drug for treating fungal dermatopathy - Google Patents
A kind of drug for treating fungal dermatopathy Download PDFInfo
- Publication number
- CN108126172A CN108126172A CN201711491073.5A CN201711491073A CN108126172A CN 108126172 A CN108126172 A CN 108126172A CN 201711491073 A CN201711491073 A CN 201711491073A CN 108126172 A CN108126172 A CN 108126172A
- Authority
- CN
- China
- Prior art keywords
- parts
- cream
- ginger
- garlic
- soaking agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Abstract
The present invention relates to a kind of drugs for treating fungal dermatopathy, it includes soaking agent and applies cream；Soaking agent weight ratio part has 13 parts of Sulfur, 0.5 1 parts of potassium permanganate, 12 parts of acetic acid, 35 parts of ginger, 35 parts of garlic, 13 parts of salt；Painting cream weight ratio part, which is made, 12 parts of 5 fluorouracil, 9 11 parts of vaseline.Soaking agent, which is pressed, matches 35 45 DEG C of warm water 1L per 100g, immersion agent solution is put into clean towel to be impregnated with, it applies a hot compress to the affected part, play softening illing skin cutin, sterilizing, ginger can distend the blood vessels the pore with promoting opening, garlic is natural plant broad-spectrum antibiotic, after completing aforesaid operations, the painting cream of above-mentioned making is applied in affected part；5 fluorouracils in cream are applied under local environment, since illing skin pore opens the capillary diastole with periphery, 5 fluorouracils are locally being easier to enter deep tissues, so as to kill fungi, and will not generate side effect, and uneasy to recur from profound.
Description
Technical field
The invention belongs to pharmaceutical technology field, more particularly, to the drug for the treatment of fungal dermatopathy.
Background technology
Fungal infection can be divided into two class of the shallow fungal infection of table and deep fungal infection, and the shallow infection of table is to invade skin by tinea bacterium
Skin, hair, caused by referring to (toe) first-class body surface, incidence is high, and harmfulness is smaller, but is brought to life, working and learning
Very big puzzlement, most skin disease particularly tickle less refined, can cause very big with symptoms such as itch, pain, bleedings
Sticky feeling and certain inferiority complex.Deep fungal infection is to invade internal organs and deep group by candida albicans and cryptococcus
Caused by knitting, incidence is low, and harmfulness is big.
Common antifungal according to site of action be divided into treatment superficial fungal infection drug have undecenoic acid, acetic acid, lactic acid,
Salicylic acid, griseofulvin, cannitracin, clotrimazole, Miconazole, econazole, bifonazole, ketoconazole etc., due to fungoid skin
Skin disease drug resistance is strong, individually with acetic acid, salicylic acid or is applied in combination, all easily recurrence.Anti- deep fungal infection drug has the fluorine born of the same parents phonetic
Pyridine, amphotericin B, nystatin, globoroseomycin, methylpartricin (mepartricin, methylpartricin sodium laurylsulfate), Fluconazole (Fluconazole, wheat Buddhist nun
Fragrant, Yi Likang), Itraconazole (Sporanox) etc., such as directly rub fungal dermatopathy with the anti-deep drug of Flucytosine
Affected part, effect is very limited, such as the injection anti-deep drug of Flucytosine, toxic side effect cause organ bad
It influences.
Invention content
The purpose of the present invention is to provide a kind of therapeutic effect is good, high efficiency, recurrence rate is low has no toxic and side effect to human body
Treatment fungal dermatopathy drug.
The object of the present invention is achieved like this, is made of two parts, wherein having soaking agent and applying cream, soaking agent is by sulphur
Huang, potassium permanganate, acetic acid, ginger, garlic, salt are according to weight ratio compatibility, by every 100g with 35-45 DEG C of warm water 1L, with clean
Towel is put into soaking agent and is impregnated with, and applies a hot compress to the affected part 3-5 minutes, impregnates towel again, gently wipe affected part, scurf is cleaned up；
Soaking agent plays softening illing skin, sterilizing, and potassium permanganate, Sulfur are killed antifungal effect and significantly improved under acidic environment；
Acetic acid provides acidic environment, and ginger can distend the blood vessels, in the case of 35-45 DEG C of temperature blood circulation accelerate, promote with
Pore open, garlic is natural plant broad-spectrum antibiotic, and allicin antibacterial effect therein is very good, the claims
The part of salt weight ratio described in 1 matches the solution of water, has bactericidal effect, and can maintain the osmotic pressure of local organization again；It completes
After aforesaid operations, the painting cream of above-mentioned making is applied in affected part, once a day, 5 days courses for the treatment of；The 5 FU 5 fluorouracil in cream is applied in office
Under portion's environment, since illing skin pore opens the capillary diastole with periphery, 5 FU 5 fluorouracil is locally being easier to enter
Deep tissues so as to kill fungi from profound level, and will not generate side effect, and isolation illing skin directly connects with extraneous again
Touch, therefore, it is of the invention the effect of clearly, it is and uneasy to recur.Its invention is as follows：
A kind of drug for treating fungal dermatopathy, it includes soaking agent and applies cream, and the raw material weight ratio of soaking agent is made
Part has 1-3 parts of Sulfur, 0.5-1 parts of potassium permanganate, 1-2 parts of acetic acid, 3-5 parts of ginger, 3-5 parts of garlic, 1-3 parts of salt；Painting is made
The raw material weight of cream has 1-2 parts of 5 FU 5 fluorouracil, 9-11 parts of vaseline than part；
As a further improvement of the above technical scheme：
It is made of following raw material medicaments：Soaking agent：3 parts of Sulfur, 1 part of potassium permanganate, 1 part of acetic acid, 5 parts of ginger, garlic 5
Part, 3 parts of salt；Apply cream：2 parts of 5 FU 5 fluorouracil, 9 parts of vaseline.
It is made of following raw material medicaments：Soaking agent：It is 1 part of Sulfur, 0.5 part of potassium permanganate, 1 part of acetic acid, 3 parts of ginger, big
3 parts of garlic, 2 parts of salt；Apply cream：1 part of 5 FU 5 fluorouracil, 9 parts of vaseline.
It is made of following raw material medicaments：Soaking agent：1 part of Sulfur, 1 part of potassium permanganate, 1 part of acetic acid, 5 parts of ginger, garlic 3
Part, 2 parts of salt；Apply cream：2 parts of 5 FU 5 fluorouracil, 11 parts of vaseline.
A kind of drug processing method of the treatment fungal dermatopathy, includes the following steps：
The preparation method of soaking agent：
The first step：Pulverizer first will be blended in by ginger, garlic and be ground into smalls；
Second step：Sulfur, potassium permanganate, acetic acid, ginger garlic mix to smalls, salt, to be placed in blender stirring mixed again
It closes 10 minutes -30 minutes；
Third walks：Examine the uniformity, 100 grams by weight either 200 grams or 300 grams or 500 grams of units are used
Glass bottle packaging；
Apply the preparation method of cream：
The first step：Vaseline, 5 FU 5 fluorouracil mixing are placed in blender and be stirred 10 minutes -30 minutes；
Second step：Examine the uniformity, 10 grams by weight either 20 grams or 30 grams of unit vials or plastics
Bottle packaging.
Advantageous effect
The present invention is made of two parts, wherein having soaking agent and applying cream, soaking agent is by Sulfur, potassium permanganate, acetic acid, life
Ginger, garlic, salt, by every 100g with 35-45 DEG C of warm water 1L, are stirred, are put with clean towel according to weight ratio compatibility
Enter soaking agent to be impregnated with, apply a hot compress to the affected part 3-5 minutes, impregnate towel again, gently wipe affected part, scurf is cleaned up；Soaking agent
Softening illing skin is played, sterilizing, sterilizing, potassium permanganate, Sulfur are killed antifungal effect and significantly carried under acidic environment
It is high；Acetic acid provides acidic environment, and ginger can distend the blood vessels, in the case of 35-45 DEG C of temperature blood circulation accelerate, promote body
On pore open, garlic is natural plant broad-spectrum antibiotic, and allicin antibacterial effect therein is very good, aforesaid right will
The solution of the part of salt weight ratio described in 1 proportioning water is sought, there is bactericidal effect, and the osmotic pressure of local organization can be maintained again；It is complete
Into after aforesaid operations, the painting cream of above-mentioned making is applied in affected part, once a day, 5 days courses for the treatment of；The 5 FU 5 fluorouracil applied in cream exists
Under local environment, due to illing skin pore open and periphery capillary diastole, 5- fluorouracils locally be easier into
Enter deep tissues, so as to kill fungi from profound level, and side effect will not be generated, and isolation illing skin directly connects with extraneous again
Touch, therefore, it is of the invention the effect of clearly, it is and uneasy to recur.Common health azole emulsifiable paste is general to profound biocidal efficacies,
Easily recurrence, if injection 5 FU 5 fluorouracil, and deleterious effect can be caused to human organ, therefore, the present invention had both solved true
The problem of bacterium dermatoses easily recur, and side effect will not be caused to human body.
Specific embodiment
With reference to embodiment, the present invention is further illustrated, and following embodiments are merely to illustrate of the invention and right
There is no limit by the present invention.
Embodiment 1, a kind of drug for treating fungal dermatopathy, weight ratio are；Soaking agent：3 parts of Sulfur, permanganic acid
1 part of potassium, 1 part of acetic acid, 5 parts of ginger, 5 parts of garlic, 3 parts of salt；Apply cream：2 parts of 5- fluorouracils, 9 parts of vaseline.
Embodiment 2, a kind of drug for treating fungal dermatopathy, weight ratio are；Soaking agent：1 part of Sulfur, permanganic acid
0.5 part of potassium, 1 part of acetic acid, 3 parts of ginger, 3 parts of garlic, 2 parts of salt；Apply cream：1 part of 5- fluorouracils, 9 parts of vaseline.
Embodiment 3, a kind of drug for treating fungal dermatopathy, weight ratio are；Soaking agent：1 part of Sulfur, permanganic acid
1 part of potassium, 1 part of acetic acid, 5 parts of ginger, 3 parts of garlic, 2 parts of salt；Apply cream：2 parts of 5- fluorouracils, 11 parts of vaseline.
Model case 1：Mr. Wang, female, 21 years old, student suffered from tinea pedis 1 year, when incipient, does not take notice of very much, at will buys
Point product, not only behind tinea pedis without improving slowly, increasingly severe instead decortication itch, festers, gets on one's shoes stink also
It is very big, influences work and life.It steeps, wash, cream, it is usable all to use, it turns from side to side repeatedly in this way more than 1 year, summer dare not also wear cool
Footwear, the shoes that a direct puncture does not expose foot the result is that the more sealing the more serious 1 year, are very itched unbearably, are treated with the present invention, due to suffering from
It is in foot, converts 35-45 DEG C of warm water with soaking agent and impregnate, itch is eliminated after 2 days, and after 1 course for the treatment of, healing of festering peels etc. it
He all eliminates tinea pedis symptom, and grows the new skin of health, and 2 course for the treatment of recoveries from illness are paid a return visit after 1 year without recurrence.
Model case 2：Lee, 39 years old, man, build was fat, suffers from jock itch, when just starting, is edge clear, slightly swells
Erythema expands gradually, has exfoliation above, switchs to brown by red gradually, through common hand itching, as a result the center of disease damage gradually from
Dynamic healing, develops, and cause many places, the edge inflammation of erythema is obvious, can have fash, blister, crust above, very to surrounding
To erosion, annular is formed.Temporary pigmentation is left more afterwards, and pruritis is serious, since affected part is special, in life and work again
Itch is hard to bear, causes very big puzzlement, and rear present invention treatment, pruritis is substantially reduced after 3 days, and blister water disappears after 1 course for the treatment of
It loses, crust is fallen, and 2 course for the treatment of recoveries from illness are paid a return visit after 1 year without recurrence.
Model case 3：Tang XX, man, 48 years old.Suffer from tinea versicolor 4 years, have round dotted macula from the beginning of abdomen, it is rear gradually to increase,
Clear-cut margin, causing adjacent damage, surrounding has new fash to occur again into big sheet, fash surface with it is a small amount of easily remove it is brown
Color furfuraceous desquamation, repeatedly treatment are never fully recovered, annual summer especially severe, after body multiple location is caused to infect, it is rear with this
Invention treatment, Schultz-Charlton after 1 course for the treatment of, decrustation are fully recovered after 2 courses for the treatment of, and follow-up 3 years is without recurrence.
The pharmacological action of drug of the present invention is as follows：
Potassium permanganate：Strong oxidizer has strong oxidizing property, has bactericidal effect, bactericidal effect is stronger under acidic environment.
Acetic acid：With bactericidal effect, while acidic environment can be provided again.
Sulfur：Effect is that external application energy desinsection is antipruritic, available for generating sulphur after mange, eczema, pruitus, with skin contact
Change hydrogen and pentathionic acid, sarcoptic mite, killing fungus can be killed, moreover it is possible to lose hair or feathers.
Ginger：Ginger can distend the blood vessels, blood circulation accelerate, promote with pore open.
Garlic：Garlic is natural plant broad-spectrum antibiotic, and allicin therein is very good to anti-bacterial effect.
Salt：Food stops Shangwan, trusted subordinate's abdominal distension, phlegm addiction in brain, constipation and anuresis, and gingiva bleeding gingival hemorrhage is had sore throat, toothache, mesh screen, sore,
Insect bite.
5 FU 5 fluorouracil：It is worked with antimetabolite, is converted into effective fluorodeoxyuridine acid in the cell
Afterwards, by the way that deoxyribouridine acid is blocked to be converted into thymidylic acid by intracellular thymidylate synthetase, and the synthesis of DNA is interfered.Fluorine
Uracil equally can be with the synthesis of RNA interfering.
Vaseline：Great chemically inert hydrocarbon, not hydrophilic, smearing can keep skin wet on the skin,
The skin histology of wound location is made to keep optimum state, the repair ability of skin itself is accelerated, stops thin in air
Bacterium and skin contact, so as to reduce the possibility of infection.
The drug processing method of the present invention, includes the following steps：
The preparation method of soaking agent：
The first step：Pulverizer first will be blended in by ginger, garlic and be ground into smalls.
Second step：Sulfur, potassium permanganate, acetic acid, ginger garlic mix to smalls, salt, to be placed in blender stirring mixed again
It closes 10 minutes -30 minutes.
Third walks：Examine the uniformity, 100 grams by weight either 200 grams or 300 grams or 500 grams of units are used
Glass bottle packaging.
Apply the preparation method of cream：
The first step：Vaseline, 5 FU 5 fluorouracil mixing are placed in blender and be stirred 10 minutes -30 minutes.
Second step：Examine the uniformity, 10 grams by weight either 20 grams or 30 grams of unit vials or plastics
Bottle packaging.
The administrated method of the present invention：Soaking agent presses the water 1L of 35-45 DEG C of the proportioning per 100g, stirs into solution, can impregnate trouble
Place also can hot compress 3-5 minute, painting cream is then applied to affected part again.
Points for attention：Forbidden eye, mouth, entering eyes accidentally needs a large amount of clear water to rinse, and see a doctor in time.
Clinical effectiveness for the drug for showing the present invention, for treating ringworm of the body, with the common health azoles emulsifiable paste of 100 uses
With 100 cases using the drug therapy ringworm of the body of the present invention, compared.
The diagnostic criteria of ringworm of the body：Ringworm of the body is as caused by fungal infection, and erythema, fash, mound occur for fungus-caused skin
The damages such as rash, blister, there is furfur, and often annular in shape etc., it is ringworm of the body to meet above-mentioned symptom.Case is equal used by this contrast test
For the case that clinical definite is ringworm of the body.
The criterion of curative effect：Recovery from illness：Fash all subsides, no scratchiness, and fungi plate coating checking is negative；It is effective：Fash
More than 60% recession, itch are alleviated or occasionally have itch, and fungi plate coating checking is negative；Effectively：Deflorescence 30%~60%, slightly
Itch, fungi plate coating checking are positive；In vain：Deflorescence is less than 30% or does not subside or aggravate, and scratchiness is more apparent, and fungi applies
Piece checks positive.Total effective rate for recovery from illness+it is effective.
Test group, 100, wherein man 52, female 48, the age at 15-60 Sui, is controlled using the drug of the present invention
It treats, administrated method is the same as above-mentioned.
Control group, 100, wherein man 55, female 45, age 15-60 Sui, the health azoles for using common treatment ringworm of the body is newborn
Cream is treated, and administrated method is to be smeared by its specification in the skin with fungi, 1-2 times daily, and 5 days are one
The course for the treatment of.
The basic conditions such as two groups of the case state of an illness, ages are suitable, there is comparativity.
Therapeutic effect is as follows.
Control group：Cure number of cases 30 (account for total number of cases 30.0%), effective number of cases 36 (account for total number of cases 36.0%), nothing
Imitate number of cases 34 (account for total number of cases 34.0%), total effective rate 76.0%；Experimental group：It cures number of cases 56 and (accounts for total number of cases
56.0%), effective number of cases 36 (36.0%), invalid number of cases 8 (account for total number of cases 8.0%), total effective rate 92.0%.
From the aforegoing it can be seen that the drug of the present invention is significantly better than fungal dermatopathy therapeutic effect the effect of health azoles emulsifiable paste
Fruit.
Finally it should be noted that embodiment is the optimal specific embodiment of the present invention, it is not limited to this
Invention, although the present invention is described in detail referring to the foregoing embodiments, for those skilled in the art, according to
So it can modify to the technical solution recorded in foregoing embodiments or which part technical characteristic is equally replaced
It changes.All within the spirits and principles of the present invention, any modification, equivalent replacement, improvement and so on should be included in the present invention
Protection domain within.
Claims (5)
1. a kind of drug for treating fungal dermatopathy, it includes soaking agent and applies cream, and the raw material weight that soaking agent is made compares part
There are 1-3 parts of Sulfur, 0.5-1 parts of potassium permanganate, 1-2 parts of acetic acid, 3-5 parts of ginger, 3-5 parts of garlic, 1-3 parts of salt；Painting cream is made
Raw material weight have 1-2 parts of 5 FU 5 fluorouracil, 9-11 parts of vaseline than part.
2. drug according to claim 1, it is characterised in that it is made of following raw materials；Soaking agent：3 parts of Sulfur, height
1 part of potassium manganate, 1 part of acetic acid, 5 parts of ginger, 5 parts of garlic, 3 parts of salt；Apply cream：2 parts of 5 FU 5 fluorouracil, 9 parts of vaseline.
3. drug according to claim 1, it is characterised in that it is made of following raw materials；Soaking agent：1 part of Sulfur, height
0.5 part of potassium manganate, 1 part of acetic acid, 3 parts of ginger, 3 parts of garlic, 2 parts of salt；Apply cream：1 part of 5 FU 5 fluorouracil, 9 parts of vaseline.
4. drug according to claim 1, it is characterised in that it is made of following raw materials；Soaking agent：1 part of Sulfur, height
1 part of potassium manganate, 1 part of acetic acid, 5 parts of ginger, 3 parts of garlic, 2 parts of salt；Apply cream：2 parts of 5 FU 5 fluorouracil, 11 parts of vaseline.
A 5. processing method for treating Fungal Skin medicine as described in claim 1, it is characterised in that including soaking agent
Preparation process and the preparation process for applying cream：
The preparation process of the soaking agent includes the following steps：
The first step：Pulverizer first will be blended in by ginger, garlic and be ground into smalls,
Second step：Sulfur, potassium permanganate, acetic acid, ginger garlic are mixed into smalls, salt again, blender is placed in and is stirred 10
- 30 minutes minute；
Third walks：Examine the uniformity, 100 grams by weight either 200 grams or 300 grams or 500 grams of unit glass
Bottle packaging；
The preparation process for applying cream includes the following steps：
The first step：Vaseline, 5 FU 5 fluorouracil mixing are placed in blender and be stirred 10 minutes -30 minutes；
Second step：Examine the uniformity, 10 grams by weight either 20 grams or 30 grams of unit vials or plastic bottle packets
Dress.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711491073.5A CN108126172A (en) | 2017-12-30 | 2017-12-30 | A kind of drug for treating fungal dermatopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711491073.5A CN108126172A (en) | 2017-12-30 | 2017-12-30 | A kind of drug for treating fungal dermatopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108126172A true CN108126172A (en) | 2018-06-08 |
Family
ID=62394138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711491073.5A Withdrawn CN108126172A (en) | 2017-12-30 | 2017-12-30 | A kind of drug for treating fungal dermatopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108126172A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972460A (en) * | 2010-10-15 | 2011-02-16 | 孟庆巨 | Composition for treating beriberi and preparation method thereof |
-
2017
- 2017-12-30 CN CN201711491073.5A patent/CN108126172A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972460A (en) * | 2010-10-15 | 2011-02-16 | 孟庆巨 | Composition for treating beriberi and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 戴文英: "用硫黄水杨酸香波治疗花斑癣", 《国际皮肤性病学杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105189732B (en) | Prevent and/or treat the method with the relevant infection of pathogenic bacteria, field planting or disease | |
| CN103908491B (en) | A kind of composition for treating tinea pedis foot odour and preparation method thereof | |
| JP2019517533A (en) | External pharmaceutical composition for treatment of various wound wounds of skin and preparation method thereof | |
| CN107303253A (en) | It is a kind of to be used to be damaged renovation agent of skin and preparation method thereof | |
| CN108669705A (en) | It is a kind of have prevention tinea pedis, the ringworm of the foot, pin sweat effect medical shoe pad | |
| CN109862882A (en) | For treating the method and composition of dermatophytid infection | |
| CN107519236A (en) | A kind of topical agent for treating onychomycosis | |
| CN106726896A (en) | A kind of beautifying health composition with anti-inflammatory bacteriostasis efficacy and preparation method thereof | |
| CN106619780A (en) | Gynecological antibacterial gel | |
| CN108126172A (en) | A kind of drug for treating fungal dermatopathy | |
| CN101579423B (en) | Medicament composition for treating beriberi and preparation method thereof | |
| CN108126173A (en) | A kind of composition of medicine for treating fungal dermatopathy and preparation method thereof | |
| CN108114254A (en) | It is a kind of for drug of fungal dermatopathy and preparation method thereof | |
| CN108452276A (en) | It is a kind of to treat superficial mycosis dermatoses composition of medicine | |
| CN107088235A (en) | The application of soapberry and its extract in amenities is prepared | |
| CN101380316A (en) | Multifunctional external antibiotic preparation and production method thereof | |
| CN101204539B (en) | Tincture medicine for tinea versicolor | |
| CN107998243A (en) | A kind of preparation method of two-component treatment tinea pedis medicine | |
| CN107137680A (en) | A kind of medicament, its preparation method and the application of antipruritic scurf removing | |
| CN105920103A (en) | External spray for treating dermatophytosis and preparation method thereof | |
| CN103285081A (en) | Corrosion cleaning liquid | |
| CN110169986A (en) | It is a kind of to treat tinea pedis, the quick-acting bastes of skirt-roof snake and its preparation application method | |
| CN1112173C (en) | Cosmetic composition containing felursi | |
| KR101447951B1 (en) | atocare healing ball and its manufacturing method | |
| CN115444779A (en) | Bactericidal composition, biological enzyme functional bath lotion prepared by applying bactericidal composition and preparation method of biological enzyme functional bath lotion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180608 |
|
| WW01 | Invention patent application withdrawn after publication |